In contrast, CTLA4-Ig at standard-dose failed to prevent or delay the onset of nephritis in Ad-IFNα treated mice despite preventing T and B cell activation, GC formation, and the production of pathogenic IgG2a anti-dsDNA antibodies (54). Here, CTLA4 is linked to nephritis.